Amesite FY26 net loss narrows to $3.1 million; revenue more than doubled to $364,777
AMST•Expenses were mixed across categories
General and administrative expense was USD 2.51 million, little changed from USD 2.48 million.
Technology and content development expense fell 11.22% to USD 613,578, while sales and marketing expense dropped 29.54% to USD 384,041.
Cash balance and going-concern warning
Cash totaled USD 2.4 million at June 30, 2026, and management said conditions raise substantial doubt about going concern.
FY26 results show narrower loss and higher revenue
Amesite posted a net loss of USD 3.1 million for fiscal 2026, narrowing from a net loss of USD 3.62 million.
Revenue more than doubled to USD 364,777 from USD 110,459, mainly from B2B license fees tied to the NurseMagic app.
